Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
5.01
+0.06 (1.21%)
Nov 20, 2024, 4:00 PM EST - Market open
Rezolute Employees
Rezolute had 59 employees as of June 30, 2024. The number of employees increased by 8 or 15.69% compared to the previous year.
Employees
59
Change (1Y)
8
Growth (1Y)
15.69%
Revenue / Employee
n/a
Profits / Employee
-$1,174,797
Market Cap
280.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
AngioDynamics | 748 |
uniQure | 480 |
Vanda Pharmaceuticals | 203 |
NeuroPace | 171 |
Nautilus Biotechnology | 167 |
Voyager Therapeutics | 162 |
Mersana Therapeutics | 123 |
RZLT News
- 2 months ago - Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment - Benzinga
- 2 months ago - US FDA lifts partial clinical hold on Rezolute's blood sugar treatment - Reuters
- 2 months ago - FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study - GlobeNewsWire
- 3 months ago - Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism - GlobeNewsWire
- 5 months ago - Rezolute Announces Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement - GlobeNewsWire
- 5 months ago - Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds - GlobeNewsWire
- 5 months ago - Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants - GlobeNewsWire